| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
11,231 |
6,239 |
$222K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
6,315 |
3,890 |
$48K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
328 |
298 |
$28K |
| 81226 |
|
430 |
387 |
$24K |
| 81225 |
|
408 |
363 |
$17K |
| 81306 |
|
251 |
231 |
$11K |
| 81227 |
|
376 |
340 |
$9K |
| 81231 |
|
347 |
312 |
$8K |
| 81232 |
|
261 |
240 |
$7K |
| 81328 |
|
260 |
239 |
$7K |
| 81335 |
|
256 |
237 |
$7K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
513 |
474 |
$7K |
| 0001A |
|
326 |
276 |
$2K |
| 81291 |
|
126 |
116 |
$1K |
| 81241 |
|
96 |
94 |
$1K |
| 0002A |
|
244 |
217 |
$1K |
| 81240 |
|
96 |
94 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
14 |
13 |
$0.00 |
| 87634 |
|
14 |
13 |
$0.00 |